Cam Gallagher

Mr. Gallagher has more than 25 years of experience in the life science and biotech industry with a focus on corporate development, marketing, operations, and early-stage investing. Prior to joining Immusoft, he was a Director and Chief Business Officer at Retrosense Therapeutics, which was acquired by Allergan in 2016. Cam was Managing Director of Nerveda, LLC, a life science seed fund he co-founded in June 2007. Cam currently serves on the board of directors of Zeno Pharma, VelosBio, SelectION, and Ocuphire Pharma. Prior to these roles, he held management positions at Verus Pharma, CV Therapeutics, and Dura Pharma. Mr. Gallagher holds an M.B.A. from the University of San Diego and a B.S. in Business Administration from Ohio University.